Calutide 50 MG Tablet contains Bicalutamide 50mg, an antiandrogen therapy used as part of combined androgen blockade or monotherapy for advanced prostate cancer management.

How It Works: Bicalutamide competes with testosterone and DHT at the androgen receptor, preventing androgen-stimulated transcription of prostate-specific genes that fuel prostate cancer growth.

Common Uses: Advanced and locally advanced prostate cancer, both in combination with LHRH analogues and as monotherapy, and adjuvant treatment after local therapy in high-risk patients.

Administration: Take one tablet once daily, consistently at the same time each day. Can be taken with or without food. Therapy duration is guided by clinical response and oncologist assessment.

Storage: Store below 30°C in a cool, dry place. Keep in original packaging and away from children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.